Trial site
Rabin Medical Center-Beilinson Campus
- 13running trials
- 11closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Ulcerative colitis3 trials
- Metastatic breast cancer2 trials
- Multiple myeloma2 trials
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Crohn's disease1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Giant cell arteritis1 trial
- Kidney cancer1 trial
- Lupus (SLE)1 trial
- and 8 more
- Phase
- Phase 316 trials
- Phase 25 trials
- Phase 1/22 trials
- Phase 11 trial
- Status
- Active, not recruiting11 trials
- Completed10 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- Daiichi Sankyo3 trials
- Abivax S.A.2 trials
- EMD Serono Research & Development Institute, Inc.2 trials
- Astellas Pharma Global Development, Inc.1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease
Recruiting
Terminated
Completed
Completed
Completed
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
Completed
Completed
Completed
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026